• Aug 08, 2022 News![International Journal of Computer Theory and Engineering] Accepted for Coverage in Scopus
  • Dec 30, 2021 News!Vol.13, No.1 & Vol.13, No.2 have been indexed by Inspec.   [Click]
  • Jul 15, 2022 News!IJCTE Vol.14, No.3 has been published.   [Click]
General Information
Prof. Mehmet Sahinoglu
Faculty at Computer Science Department, Troy University, USA
I'm happy to take on the position of editor in chief of IJCTE. We encourage authors to submit papers concerning any branch of computer theory and engineering.

The Advances in Computer Theory & Software Engineering on Covid Pandemic(s) and/or Incurable Killer Diseases

Submission Deadline: August 31, 2022

Chief Editor

Dr. Mehmet Sahinoglu
Faculty at Computer Science Department, Troy University, USA

Guest Editor

Dr. Sedat Capar
Department of Statistics, Faculty of Science, Dokuz Eylul University, Turkey

Special Issue Information 

The submitted regular full research computer-scientific theoretical and applied papers of original nature, not printed elsewhere, subject to peer-review should be of innovative nature to add to the existing state of knowledge on various pandemics including the advancement of hospital/healthcare networking and/or those including the currently incurable physical and neurological killer diseases of our times such as CANCER, CARDIOVASCULAR, ASTHMA, HIV/AIDS, DEMENTIA (e.g. ALZHEIMER's,  PARKINSON's, HUNTINGDON's and VASCULAR etc.), MS (Multiple Sclerosis), MD (Muscular Dystrophy),  MOTOR NEURON Disorders such as ALS (Lou Gehrig's Disease) to name a few , among others. These diseases'  cures non-existent, however, are still being researched by the world's prominent institutes of health and vaccine research, specifically the recent epidemic COVID-19 (as of Feb. 20, 2022 totaling globally to ~6m deaths and ~346m recovered out of ~421m CORONAVIRUS cases, with remaining ~69m currently infected).
The goal is what, why and how to avoid the unprecedented misery triggered by such diseases or disorders; for a vivid prevalent example, by the previous(*see Table 1 below [Source]) and current pandemics (SARS-CoV-2). The IJCTE is fully encouraging scientific methodologies (via software) and technologies (via hardware)  in the realm of medicinal sciences, health information sciences, biomedical engineering, virology, microbiology, molecular biology, bacteriology, genomics, pulmonology, clinical psychology, applied mathematical and statistical sciences (operations research, sampling, hypothesis testing, estimation, empirical Bayesian, safety and reliability, game theoretic and neural network frameworks...) and immunology and similar, whereas also in peripheral real disciplines addressing the core issue of pandemics' or  incurable killer diseases' disaster recognition, mobilization, remediation and immunization efforts, but not limited to all above.

Key Words:

COVID-19, Virus, Cases, Recovery, PCR, False Negative, Mobilization, Vaccination, Antibody, WHO (World Health Organization)

Manuscript Submission Information 

Authors should submit via online submission system: http://ojs.ejournal.net/index.php/ijcte/submission. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles and review articles are invited. For planned papers, a title and short abstract (about 100 words) can be sent to guest editor for perusal first.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere. All manuscripts are thoroughly refereed through a blind peer-review process. A guide for authors and other relevant information for submission of manuscripts are available on the Author Submission Guide page.

The Article Processing Charge in IJCTE is 350 USD. Each paid fee is entitled to one published paper regardless of the length of the paper. The article processing charge is mandatory.

Published Papers 

Copyright © 2008-2022. International Association of Computer Science and Information Technology. All rights reserved.